SCHEMBL14947835

SCHEMBL14947835

CCCCC(CC)CN(CC(CC)CCCC)C(=O)c1cc(N/N=C(/C(C)=O)C(=O)Nc2ccc([N+](=O)[O-])cc2)cc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.39
MAPT P10636 9/20 0.39
MEN1 O00255 9/20 0.39
POLB P06746 2/20 0.38
ALDH1A1 P00352 9/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
HTT P42858 5/20 0.37
GAA P10253 4/20 0.37
GFER P55789 2/20 0.36
MAPK1 P28482 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 3/20 0.36
LMNA P02545 2/20 0.36
PKM P14618 1/20 0.36
PAX8 Q06710 1/20 0.36
KDM4E B2RXH2 1/20 0.36
THRB P10828 1/20 0.36
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14947842 0.88 MAPT (0.34) KMT2AMAPTMEN1ALDH1A1SMN1; SMN2
SCHEMBL14950965 0.87 POLB (0.40) KMT2AMAPTMEN1POLBALDH1A1
SCHEMBL10074607 0.81 KDM4E (0.39) KMT2AMAPTPOLBALDH1A1GAA
SCHEMBL14947847 0.78 ALDH1A1 (0.48) KMT2AMAPTMEN1POLBALDH1A1
SCHEMBL23489924 0.77 CRHBP (0.49) KMT2AMAPTPOLBALDH1A1SMN1; SMN2
SCHEMBL14947844 0.77 ATM (0.42) KMT2AMAPTMEN1POLBALDH1A1
SCHEMBL9679694 0.74 ATM (0.39) MAPTPOLBALDH1A1SMN1; SMN2GAA
SCHEMBL12299588 0.66 GFER (0.47) KMT2AMAPTMEN1POLBALDH1A1
SCHEMBL5145421 0.66 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2HTT
SCHEMBL10074609 0.66 ALDH1A1 (0.39) ALDH1A1HTTMAPK1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815485-B2 Azo compound, pigment dispersant containing the azo compound, pigment composition, pigment dispersion, and toner CANON KABUSHIKI KAISHA (JP) 2014-08-26 US disclosed
US-8815485-B2 Azo compound, pigment dispersant containing the azo compound, pigment composition, pigment dispersion, and toner CANON KABUSHIKI KAISHA (JP) 2014-08-26 US disclosed
US-20130122413-A1 AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER CANON KABUSHIKI KAISHA (JP) 2013-05-16 US disclosed
US-20130122413-A1 AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER CANON KABUSHIKI KAISHA (JP) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130122413-A1 AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER TYR, CRY1, MITF KMT2A 556/4885MAPT 99/4885MEN1 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.